|
||
TWN Info Service on Intellectual Property Issues
(Aug10/01) Dear friends and colleagues, Inter-governmental negotiations for a new international
treaty under the Convention on Biological Diversity, to prevent biopiracy
and implement the fair and equitable benefit sharing objective of the
Convention, will resume for an additional week on 18-21 September in
To facilitate the negotiations, an Inter-regional
Negotiations Group was set up in July. It is unique in its inclusiveness,
consisting of five spokespersons self-selected from among the Parties
from each of the five UN regions, two representatives each from Indigenous
and Local Communities, Civil Society, Research Institutions and Private
Sector, as well as the current (Germany) and incoming (Japan) COP Presidencies.
These representatives can be replaced, as needed, by each grouping.
All other Parties, non-Parties and observers are also in the room to
ensure transparency of the proceedings. Observers at the table can provide
"guidance" on the items being negotiated while textual inputs
are the prerogative of the Parties. As the report below shows, there are still fundamental differences, primarily between developing and developed countries on addressing the deep injustice of biopiracy. An earlier version of the article below was published in SUNS #6970 Wednesday 21 July 2010.
Access and benefit-sharing Protocol negotiations resume in September The 193 Parties to the Convention on Biological
Diversity (CBD) have mandated the Ad Hoc Open-ended Working Group on
Access and Benefit-Sharing (ABS) to finalise the Protocol under the
CBD in time for adoption when the Parties convene its biennial meeting
in October 2010 in The Working Group was to complete its work at
its ninth meeting in The Working Group established the Interregional
Negotiating Group (ING) at its opening plenary session on 10 July for
this purpose. The ING consists of five spokespersons self-selected from
among the Parties from each of the five UN regions, two representatives
each from Indigenous and Local Communities, Civil Society, Research
Institutions and Private Sector, as well as the current ( Three out of 32 Articles of the draft Protocol
were agreed to by the end of the The significant progress made in The International Indigenous Forum on Biodiversity
that is an active part of the ABS Protocol process expressed deep disappointment
throughout the week, that a number of important provisions in the draft
text related to the rights of indigenous peoples that had undergone
extensive negotiations in Contested scope: relationship with other instruments and “derivatives” of genetic resources The scope of the Protocol emerged as a central contentious issue, with many developed country Parties seeking to exclude crucial sectors from the application of the Protocol or to effectively subordinate the Protocol to other international instruments and processes. Almost all developed countries preferred to prioritise intellectual property rights obligations while developing countries pointed to the CBD’s own provision (Article 16.5) calling for IPRs to be “supportive of, and not run counter to the CBD objectives”. The temporal scope of the Protocol (i.e. whether benefits from the use of genetic resources acquired before the entry into force of the Protocol should be included, especially those in ex situ gene banks and botanical gardens in developed countries) and the geographical scope (i.e. developed countries object to benefit sharing coverage with regard to areas beyond national jurisdiction such as the Antarctica area) are also unresolved issues. The issue of pathogens was heatedly debated in
During that debate, Malaysia (on behalf of the Like Minded Asia Pacific Group) and New Zealand both said that they found the EU proposal “startling” as its call for immediate access applied regardless of whether there was an emergency situation. The EU proposal also covers plant and animal pathogens. South Africa (on behalf of the Africa Group) questioned the basis upon which health pandemics are assessed, emphasizing how African countries had no access to the relevant vaccines when the recent H1N1 (“swine”) influenza pandemic was declared by the WHO. Benefit sharing according to the CBD objectives and principles was therefore crucial. Against the backdrop of the ongoing debate a small group in Montreal produced the following “relationship provision” which relates to the relationship of the Protocol with other international instruments and agreements, with consensus on most parts except for those with brackets to indicate the areas with no consensus: “Article 3bis [1. The provisions of this Protocol shall not affect the rights and obligations of any Contracting Party deriving from any existing international agreement, except where the exercise of those rights and obligations would cause a serious damage or threat to biodiversity. This paragraph is not intended to subordinate the Protocol to other international instruments] 2. Nothing in this Protocol shall prevent
the Parties from developing and implementing other relevant international
agreements, including other specialized access and benefit-sharing agreements,
provided that they are supportive of and do not run counter to the objectives
of the Convention and this Protocol. 4. This Protocol is the instrument for the implementation of access and benefit-sharing provisions of the Convention. Where a specialized international access and benefit-sharing instrument applies that is consistent with, and does not run counter to, the objectives of the Convention and of this Protocol, this Protocol does not apply for the Contracting Party or Parties to the specialized instrument in respect of the specific genetic resource covered by and for the purpose of the specialized instrument. Related to scope is the issue of “derivatives”
of genetic resources. All along most developed country Parties and their
industries have argued against inclusion of derivatives for the purposes
of ensuring compliance with benefit-sharing terms and prior informed
consent. They prefer that benefit sharing of derivatives be dealt with
in bilateral contracts (“mutually agreed terms” as stated in the CBD)
between users and providers, without the government having an important
role. With only seven days left, Parties at the In an unexpected move, during the first reading of the draft Articles on institutional issues of the Protocol, the EU proposed that there was no need to establish a separate governance structure for the ABS Protocol. It said that implementation of the Protocol can be included as an item in the agenda and work programme of the CBD’s Conference of the Parties (COP). The usual practice is that the COP of a main treaty acts as the “Meeting of the Parties” of a Protocol that has been developed under that treaty and the MOP is legally separate and distinctive. The EU argued that ABS is an issue that is addressed by the CBD as well and therefore the CBD COP can address all ABS issues in the same forum. This proposal evoked strong reactions from developing
countries, with the various groups’ spokespersons presenting counter-arguments
to the EU proposal. They argued that if the Protocol were to be subsumed
into another item in a CBD COP agenda, it would not result in the effective
implementation of benefit-sharing objective of the CBD. The core issues of the Protocol had been identified
earlier in In explaining the "rules of engagement" at the opening plenary Co-Chair Casas urged Parties to "exercise maximum restraint" and "avoid insertions that only reflect your positions". Any proposed text should improve the draft protocol and "accommodate the views of others". He stressed that Parties should try to accommodate each other’s concerns while ensuring their own interests were reflected, in a balanced manner bearing in mind that the protocol is to implement the CBD's 3rd objective of fair and equitable benefit sharing. The ING went through the substantive parts of the draft text contained in Articles 1-19 by Monday 12 July, except for Article 2 (Use of Terms) that will be left till the end of the process. These Articles include provisions dealing with: Objective, Scope, Fair and Equitable Benefit-Sharing, Access to Genetic Resources, Access to Traditional Knowledge Associated with Genetic Resources, Considerations relevant to Research and Emergency Situations, Transboundary Cooperation, Compliance with National ABS Legislation, Monitoring, Tracking and Reporting the Utilization of Genetic Resources, Non-Compliance with Mandatory Disclosure Requirements, Compliance with Mutually Agreed Terms, International ABS Ombudsperson, Model Contractual Clauses, Codes of Conduct, Guidelines and Best Practice Standards, Awareness Building, Capacity, technology Transfer and Cooperation, Non-Parties and Financial Mechanism and Resources. A second reading of the bulk of the revised draft of these Articles was conducted after the plenary held on Tuesday, 13 July to assess progress. The Co-Chairs assigned small groups of key negotiators from the various Parties’ groupings with specific issues to resolve, and these informal meetings were open to other interested Parties. The text of two clusters of issues were given to two small groups to try to arrive at a consensus: (i) the relationship between the Protocol with other instruments (resolving this would hopefully deal with the list of exclusions and reservations currently in the Article on Scope); and (ii) institutional and final clauses. Another small group was tasked with trying to
reach a common understanding of “derivatives” and the concept of utilization
of genetic resources in the context of benefit-sharing. This group facilitated
by The Co-Chairs then reconvened this small group
(this time under the facilitation of (Article 15.7 of the CBD obliges Parties to take legislative, administrative or policy measures, as appropriate, with the aim of sharing in a fair and equitable way the results of research and development and the benefits arising from the commercial and other utilization of genetic resources with the Party providing such resources. “Commercial and other utilization” is interpreted by developing countries to mean “any utilization”.) The agreed footnote reads as follows: 'utilization of genetic resources’ includes/means the conduct of research and development, on the genetic and biochemical makeup/composition of genetic material/biological resources, including through the application of biotechnology as defined in Article 2 of the Convention on Biological Diversity, as well as subsequent applications and commercialization.” Yet another small group was tasked to deal with the inter-linkages among the Protocol provisions that the Co-Chairs said are the “core of the core” that will unlock the other provisions of the draft Protocol. This met on 15 July night and on 16 July until the closing plenary of the Working Group in the afternoon. It identified three issues that, to all Parties in the room, would be the key for consensus to be achieved. The ING also conducted a first reading of the preamble, with Parties adding numerous paragraphs to safeguard their respective positions on a range of issues that still remained contentious in the main body of the draft Protocol. Most of them relate to the relationship of the Protocol with other international instruments A simple list of preambular paragraphs that was a little more than a page in the original Co-Chair’s draft has been expanded to more than three pages. Negotiations on these will be in the next resumed session in September. A first reading was also made of the Articles dealing with institutional issues and the usual treaty-establishing provisions (Articles 20 to 31). The three agreed Articles The Montreal meeting agreed in full to the following: Article 7 on Contribution to Conservation and Sustainable Use: “Parties shall encourage users and providers to direct benefits arising from the utilization of genetic resources towards the conservation and sustainable use of biodiversity in support of the CBD objectives.” Article 8 on Transboundary Cooperation, paragraph 1: “In instances where the same genetic resources are found in situ within the territory of more than one Party, those Parties shall endeavor to cooperate, as appropriate, with the involvement of indigenous and local communities concerned, where applicable, with a view to implementing this Protocol.” The same provision is made for traditional knowledge associated with genetic resources that is shared by one or more community several countries, contained in paragraph 2. Rocky road still ahead However, the European Union, Late on Monday (12 July) night, after an extensive re-writing by the EU of the compliance provisions, the groupings of Asia Pacific, African and Latin Mexican and Caribbean countries complained in exasperation. The Co-Chairs were also visibly frustrated because the result was a text that had lost the original balance with many points of disagreement. At the plenary session held on Tuesday afternoon (13 July) for negotiators to conduct a “self-assessment” on the status of their work, the Co-Chairs told negotiators that they had made “considerable real progress” but they still had a way to go. Mr. Hodges said that, “Finalizing the protocol is within your grasp. But the time is passing. We need to finish by Friday”. The Namibian delegate speaking for the Africa
Group expressed strong frustration during the assessment discussion.
He said The representative of Many Parties and observers are concerned that
In the same plenary The Co-Chair Hodges assured the delegation that this request will be reflected in the report of the meeting. The ABS Working Group Co-Chairs promised to work with the Executive Secretary to find the necessary resources in order to fund the meeting and maintain its inclusiveness, meaning that as many countries as possible should be funded to be able to attend the meeting, notwithstanding the fact that the actual negotiations is done by a limited number of countries sitting in the Inter-regional Negotiating Group. Africa expressed its concern that the delegates
coming to the further resumed 9th meeting of the Working Group will
have done the necessary consultations and possess the necessary political
mandate to finalize the negotiations and that not more than 10 minutes
would be necessary to adopt the Protocol in
|